"Influenza Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more INFLUENZAVIRUS A and INFLUENZAVIRUS B strains.
| Descriptor ID |
D007252
|
| MeSH Number(s) |
D20.215.894.899.302
|
| Concept/Terms |
Influenza Vaccines- Influenza Vaccines
- Influenza Vaccine
- Vaccine, Influenza
- Flu Vaccines
- Influenzavirus Vaccines
- Influenza Virus Vaccines
- Influenza Virus Vaccine
- Vaccine, Influenza Virus
- Virus Vaccine, Influenza
|
Below are MeSH descriptors whose meaning is more general than "Influenza Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Influenza Vaccines".
This graph shows the total number of publications written about "Influenza Vaccines" by people in this website by year, and whether "Influenza Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 2 | 0 | 2 |
| 2004 | 2 | 2 | 4 |
| 2005 | 3 | 0 | 3 |
| 2006 | 7 | 0 | 7 |
| 2007 | 3 | 0 | 3 |
| 2008 | 3 | 0 | 3 |
| 2009 | 5 | 0 | 5 |
| 2010 | 3 | 0 | 3 |
| 2011 | 15 | 1 | 16 |
| 2012 | 12 | 2 | 14 |
| 2013 | 12 | 1 | 13 |
| 2014 | 7 | 1 | 8 |
| 2015 | 3 | 1 | 4 |
| 2016 | 6 | 2 | 8 |
| 2017 | 11 | 1 | 12 |
| 2018 | 3 | 0 | 3 |
| 2019 | 3 | 3 | 6 |
| 2020 | 11 | 0 | 11 |
| 2021 | 3 | 0 | 3 |
| 2022 | 5 | 0 | 5 |
| 2023 | 9 | 0 | 9 |
| 2024 | 15 | 0 | 15 |
To return to the timeline,
click here.
Below are the most recent publications written about "Influenza Vaccines" by people in Profiles.
-
Reduced Effectiveness of Repeat Influenza Vaccination: Distinguishing Among Within-Season Waning, Recent Clinical Infection, and Subclinical Infection. J Infect Dis. 2024 Dec 16; 230(6):1309-1318.
-
Molecular features of the serological IgG repertoire elicited by egg-based, cell-based, or recombinant haemagglutinin-based seasonal influenza vaccines: a comparative, prospective, observational cohort study. Lancet Microbe. 2025 Feb; 6(2):100935.
-
Comparative Effectiveness of Cell-Based Versus Egg-Based Influenza Vaccines in Prevention of Influenza Hospitalization During the 2022-2023 Season Among Adults 18-64?Years. Influenza Other Respir Viruses. 2024 Dec; 18(12):e70025.
-
Comparative Effectiveness of Licensed Influenza Vaccines in Preventing Influenza-related Medical Encounters and Hospitalizations in the 2022-2023 Influenza Season Among Adults =65 Years of Age. Clin Infect Dis. 2024 Nov 22; 79(5):1283-1292.
-
Estimated Effectiveness of Influenza Vaccines in Preventing Secondary Infections in Households. JAMA Netw Open. 2024 Nov 04; 7(11):e2446814.
-
Elevated body mass index is not significantly associated with reduced influenza vaccine effectiveness. Sci Rep. 2024 09 13; 14(1):21466.
-
Safety of the Seasonal Influenza Vaccine in 2 Successive Pregnancies. JAMA Netw Open. 2024 Sep 03; 7(9):e2434857.
-
Influenza Vaccine Effectiveness Against Influenza A-Associated Emergency Department, Urgent Care, and Hospitalization Encounters Among US Adults, 2022-2023. J Infect Dis. 2024 Jul 25; 230(1):141-151.
-
Antibody response to sequential vaccination with cell culture, recombinant, or egg-based influenza vaccines among U.S. adults. Hum Vaccin Immunother. 2024 Dec 31; 20(1):2370087.
-
Ipsilateral and contralateral coadministration of influenza and COVID-19 vaccines produce similar antibody responses. EBioMedicine. 2024 May; 103:105103.